restarting semaglutide after a month Your Weight Loss Journey? Why "Stocking Up" at High Dose Can Be a Dangerous How to Restart GLP-1 Medications

As the semaglutide patent expiries begin in 2026 across key global markets, Indian pharma companies are racing to capture the opportunity amid rising competition, falling prices & regulatory uncertainty Ekta Bhatra breaks down who stands to gain, the risks ahead, & how GLP-1 drugs could drive the next phase of pharma growth

Our volumiz

Reddy's, Alkem, Mankind, and Glenmark have all moved quickly to develop and launch their own versions

Unlock your weight loss potential with Tirzepatide

Here we review evolving concepts of incretin action, focusing predominantly on GLP-1, from discovery, to clinical proof of concept, to therapeutic outcomes

Does GLP-1 show up in blood work